Home › Encyclopedia › Pralmorelin (GHRP-2): Research Status and Facts
Research / Unapproved

Pralmorelin (GHRP-2): Research Status and Facts

Molecular formulaC45H55N9O6
Molecular weight818 g/mol
Registered trials0
PubChem CID6918245

Anyone researching pralmorelin, also known as GHRP-2, should first understand where it stands regulatorily. This compound is classified as unapproved and is not the subject of any FDA-approved drug label.

What pralmorelin is

Pralmorelin is a synthetic peptide with the molecular formula C45H55N9O6 and a molecular weight of about 818. It is cataloged in PubChem under CID 6918245, an identifier used for chemical reference rather than clinical guidance. No FDA-approved label, indication, mechanism description, or brand name exists for this compound in the available data. Because there is no approved labeling, no drug class or mechanism of action can be stated from regulatory sources.

Trial footprint

The available registry data shows zero registered clinical trials for pralmorelin. No trial samples, phases, or statuses are available to summarize. This absence of trial records means there is no clinical evidence base described here regarding safety or effects in humans.

FAQ

Is pralmorelin FDA approved?
No. Pralmorelin does not have an FDA-approved label or any approved indication. It is classified as an unapproved research compound.
What is pralmorelin also known as?
Pralmorelin is also referred to as GHRP-2. It is a synthetic peptide identified in PubChem under CID 6918245.
Are there clinical trials studying pralmorelin?
According to the available registry data, there are zero registered clinical trials for pralmorelin. No trial samples or phase information are available.
What is the chemical composition of pralmorelin?
Pralmorelin has the molecular formula C45H55N9O6 and a molecular weight of approximately 818. This chemical data is drawn from PubChem records.
Is there safety data available for pralmorelin?
No adverse event report data is available for pralmorelin in this dataset. In the absence of an approved label or trial records, no safety profile can be summarized here.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 6918245

Updated 2026-09-19